Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Plasma apelin: A novel biomarker for predicting diabetes.

Ma WY, Yu TY, Wei JN, Hung CS, Lin MS, Liao YJ, Pei D, Su CC, Lu KC, Liu PH, Lin CH, Chuang LM, Kao HL, Lin JW, Chuang YJ, Li HY.

Clin Chim Acta. 2014 Aug 5;435:18-23. doi: 10.1016/j.cca.2014.03.030. Epub 2014 Apr 8.

PMID:
24721640
2.

Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus.

Erdem G, Dogru T, Tasci I, Sonmez A, Tapan S.

Exp Clin Endocrinol Diabetes. 2008 May;116(5):289-92. doi: 10.1055/s-2007-1004564.

PMID:
18484561
3.

Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects.

Li L, Yang G, Li Q, Tang Y, Yang M, Yang H, Li K.

Exp Clin Endocrinol Diabetes. 2006 Nov;114(10):544-8.

PMID:
17177135
4.

Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes.

Akinci B, Celtik A, Tunali S, Genc S, Yuksel F, Secil M, Ozcan MA, Bayraktar F.

Arch Gynecol Obstet. 2014 Apr;289(4):787-93. doi: 10.1007/s00404-013-3070-y. Epub 2013 Nov 2.

PMID:
24185940
5.

Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control.

Habchi M, Duvillard L, Cottet V, Brindisi MC, Bouillet B, Beacco M, Crevisy E, Buffier P, Baillot-Rudoni S, Verges B, Petit JM.

Clin Endocrinol (Oxf). 2014 Nov;81(5):696-701. doi: 10.1111/cen.12404. Epub 2014 Feb 4.

PMID:
24417455
7.

A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed.

Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L.

J Intern Med. 2006 Sep;260(3):263-71. Erratum in: J Intern Med. 2006 Nov;260(5):491.

8.

HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP).

Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention Program (EDIP).

Diabetes Care. 2001 Mar;24(3):465-71.

PMID:
11289469
9.

Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus.

Kadoglou NP, Tsanikidis H, Kapelouzou A, Vrabas I, Vitta I, Karayannacos PE, Liapis CD, Sailer N.

Metabolism. 2010 Mar;59(3):373-9. doi: 10.1016/j.metabol.2009.08.005. Epub 2009 Oct 7.

PMID:
19815243
10.

Apelin serum levels are not associated with early atherosclerosis or fat distribution in young subjects with increased risk for type 2 diabetes.

Rittig K, Hildebrandt U, Thamer C, Staiger H, Peter A, Stefan N, Fritsche A, Häring HU, Balletshofer BM, Siegel-Axel D.

Exp Clin Endocrinol Diabetes. 2011 Jun;119(6):358-61. doi: 10.1055/s-0030-1268466. Epub 2011 Jan 24.

PMID:
21264801
11.

Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.

Cavallo MG, Sentinelli F, Barchetta I, Costantino C, Incani M, Perra L, Capoccia D, Romeo S, Cossu E, Leonetti F, Agati L, Baroni MG.

PLoS One. 2012;7(12):e51236. doi: 10.1371/journal.pone.0051236. Epub 2012 Dec 5.

12.

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T; Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus.

Diabetes Res Clin Pract. 2002 Jan;55(1):65-85.

PMID:
11755481
13.

An abnormal apelin/vasopressin balance may contribute to water retention in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) and heart failure.

Blanchard A, Steichen O, De Mota N, Curis E, Gauci C, Frank M, Wuerzner G, Kamenicky P, Passeron A, Azizi M, Llorens-Cortes C.

J Clin Endocrinol Metab. 2013 May;98(5):2084-9. doi: 10.1210/jc.2012-3794. Epub 2013 Mar 20.

PMID:
23515451
14.
15.

Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.

Oncul M, Tuten A, Erman H, Gelisgen R, Benian A, Uzun H.

Minerva Med. 2013 Oct;104(5):527-35.

PMID:
24101110
16.

Apelin: a peptide involved in cardiovascular risk in hemodialysis patients?

Leal VO, Lobo JC, Stockler-Pinto MB, Farage NE, Calixto A, Geloneze B, Mafra D.

Ren Fail. 2012;34(5):577-81. doi: 10.3109/0886022X.2012.668490. Epub 2012 Mar 15.

PMID:
22417287
17.

Elevated plasma levels of apelin in children with type 1 diabetes mellitus.

Meral C, Tascilar E, Karademir F, Tanju IA, Cekmez F, Ipcioglu OM, Ercin CN, Gocmen I, Dogru T.

J Pediatr Endocrinol Metab. 2010 May;23(5):497-502.

PMID:
20662349
18.

Dose-response effect of pioglitazone on insulin sensitivity and insulin secretion in type 2 diabetes.

Miyazaki Y, Matsuda M, DeFronzo RA.

Diabetes Care. 2002 Mar;25(3):517-23.

PMID:
11874940
19.

Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertension.

Papadopoulos DP, Makris T, Perrea D, Zerva K, Tsioufis C, Faselis C, Papademetriou V.

J Clin Hypertens (Greenwich). 2014 Mar;16(3):198-201. doi: 10.1111/jch.12260. Epub 2014 Feb 20.

20.

Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, Eschwege E; DESIR Study Group.

Diabetes Care. 2006 Jul;29(7):1619-25.

PMID:
16801588

Supplemental Content

Support Center